NRPLUS MEMBER ARTICLE
hen the announcement came on October 2 that President Trump had tested positive for COVID-19, his supporters — and more than a few critics — prayed for his speedy recovery. At the age of 74 and with at least one significant comorbidity, Trump was at high risk of a severe and potentially fatal bout of COVID-19.
Little did he or anyone else know, his timing could not have been better. Just three days earlier, a company called Regeneron Pharmaceuticals announced that clinical trials of its futuristic new treatment had succeeded in reducing both infection and the time it takes for alleviation